GPR40 agonists
    2.
    发明授权
    GPR40 agonists 有权
    GPR40激动剂

    公开(公告)号:US07750048B2

    公开(公告)日:2010-07-06

    申请号:US11939039

    申请日:2007-11-13

    IPC分类号: A61K31/192 C07C59/64

    摘要: The invention is directed to compounds of Formula (I) useful as GPR40 agonists. Pharmaceutical compositions and methods of treating one or more conditions including, but not limited to, insulin resistance, hyperglycemia, obesity, diabetes such as NIDDM, and other disorders related to lipid metabolism, energy homeostasis, and complications thereof, using compounds of the invention are also described.

    摘要翻译: 本发明涉及用作GPR40激动剂的式(I)化合物。 使用本发明化合物治疗一种或多种病症的药物组合物和方法,包括但不限于胰岛素抵抗,高血糖症,肥胖症,糖尿病如NIDDM,以及与脂质代谢相关的其它障碍,能量稳态及其并发症, 也描述。